Filing Flows

Filing Flows › DocGo (DCGO) › Guidance & outlook

DocGo (DCGO) guidance and outlook

DocGo's 10-Q filed Nov 9, 2026 makes 32 forward-looking statements.

Guidance and outlook

DocGo: what its forward-looking statements are about (10-Q filed 2026-11-09)DocGo: what its forward-looking statements are about (10-Q filed 2026-11-09)Other11Demand8Costs8People2Legal & regulation1Financing1The economy1
32 statements; tone +0.03 (−1 all cautious, +1 all confident); 7 hedged.
DocGo: outlook statements against the filing beforeDocGo: outlook statements against the filing beforeConfident11Cautious10

Forward-looking statements, 10-Q filed Nov 9, 2026

DocGo's latest quarter

DocGo, Q3 2026: revenue $73.4M (+4% year over year), operating margin -23.5%, net loss $18.3M, operating cash flow −$3.6M. The chart follows the revenue to costs, profit and cash.

Questions

What does DocGo expect?

Future revenue growth and improvement in operating results will be largely contingent on our ability to penetrate new markets and further penetrate existing markets, which is subject to a number of uncertainties, many of which are beyond our control. We believe the market will also grow if hospitals and other healthcare facilities continue to outsource more of their transportation needs to independent providers, such as the Company, allowing these facilities to concentrate their efforts on their core competencies. We expect these fixed rate, “leased hour” programs to continue to account for an

Open the interactive view →

Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.